Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.

Abstract Aim: To explore the role of cannabis use for the availability of ecstasy as a potential pathway to subsequent first ecstasy use. Methods: Baseline and 4-year follow-up data from a prospective-longitudinal community study of originally 3021 adolescents and young adults aged 14–24 years at baseline were assessed using the standardized M-CIDI and DSM-IV criteria. Results: Baseline cannabis users reported at follow-up more frequent access to ecstasy than cannabis non-users. Higher cannabis use frequencies were associated with increased ecstasy availability reports. Logistic regression analyses revealed that cannabis use and availability of ecstasy at baseline are predictors for incident ecstasy use during the follow-up period. Testing simultaneously the impact of prior cannabis use and ecstasy availability including potential confounders, the association with cannabis use and later ecstasy use was confirmed (OR = 6.3; 95%CI = 3.6–10.9). However, the association with ecstasy availability was no longer significant (OR = 1.2; 95%CI = 0.3–3.9). Conclusions: Results suggest that cannabis use is a powerful risk factor for subsequent first onset of ecstasy use and this relation cannot be sufficiently explained by availability of ecstasy in the observation period.

[1]  L. Robins,et al.  The sixth Thomas James Okey Memorial Lecture. Vietnam veterans' rapid recovery from heroin addiction: a fluke or normal expectation? , 1993, Addiction.

[2]  K. L. Jansen,et al.  Ecstasy (MDMA) dependence. , 1999, Drug and alcohol dependence.

[3]  H. Wittchen,et al.  Early Developmental Stages of Psychopathology Study (EDSP): Objectives and Design , 1998, European Addiction Research.

[4]  D. Kandel,et al.  Patterns of drug use from adolescence to young adulthood: III. Predictors of progression. , 1984, American journal of public health.

[5]  J. Anthony,et al.  Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. , 2002, American journal of epidemiology.

[6]  H. Wittchen,et al.  Prevalence of Use, Abuse and Dependence of Illicit Drugs among Adolescents and Young Adults in a Community Sample , 1998, European Addiction Research.

[7]  M. Höfler,et al.  Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? , 2000, European Psychiatry.

[8]  Bruce Johnson.  Marihuana users and drug subcultures , 1973 .

[9]  L J Horwood,et al.  Early onset cannabis use and psychosocial adjustment in young adults. , 1997, Addiction.

[10]  D. Kandel,et al.  Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. , 1992, Journal of studies on alcohol.

[11]  D. Fergusson,et al.  The origins of the correlations between tobacco, alcohol, and cannabis use during adolescence. , 1998, Journal of child psychology and psychiatry, and allied disciplines.

[12]  W. Hall,et al.  The relationship between cannabis use and other substance use in the general population. , 2001, Drug and alcohol dependence.

[13]  A. Bauman,et al.  Epidemiology of substance use in adolescence: prevalence, trends and policy implications. , 1999, Drug and alcohol dependence.

[14]  D. Kandel.  Does marijuana use cause the use of other drugs? , 2003, JAMA.

[15]  R. Smart,et al.  Drug use and drinking among students in 36 countries. , 2000, Addictive behaviors.

[16]  P. Schuster,et al.  Structure, Content and Reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) Substance Use Sections , 1998, European Addiction Research.

[17]  G. Di Chiara,et al.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. , 1997, Science.

[18]  D. Kandel,et al.  Patterns of drug use from adolescence to young adulthood: II. Sequences of progression. , 1984, American journal of public health.

[19]  A. Steiger,et al.  To what degree does the Composite International Diagnostic Interview (CIDI) correctly identify DSM‐IV disorders? Testing validity issues in a clinical sample , 1998 .

[20]  R. Thomasius,et al.  [MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae]. , 1997, Fortschritte der Neurologie-Psychiatrie.

[21]  L. Kraus,et al.  Repräsentativerhebung zum Gebrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland 2000 Population Survey on the Consumption of Psychoactive Substances in the German Adult Population 2000 , 2001 .

[22]  M. Höfler,et al.  Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults , 2003, Psychological Medicine.

[23]  D. Fergusson,et al.  Does cannabis use encourage other forms of illicit drug use? , 2000, Addiction.

[24]  K. Kendler,et al.  Cannabis and Other Illicit Drugs: Comorbid Use and Abuse/Dependence in Males and Females , 2004, Behavior genetics.

[25]  H. Wittchen,et al.  Patterns of Use and Their Relationship to DSM-IV Abuse and Dependence of Alcohol among Adolescents and Young Adults , 1998, European Addiction Research.

[26]  H. Wittchen,et al.  SKID II. Strukturiertes Klinisches Interview für DSM-IV, Achse II: Persönlichkeitsstörungen. Interviewheft. Eine deutschspeachige, erw. Bearb. d. amerikanischen Originalversion d. SKID-II von: M.B. First, R.L. Spitzer, M. Gibbon, J.B.W. Williams, L. Benjamin, (Version 3/96). , 1997 .

[27]  Tx Station.  Stata Statistical Software: Release 7. , 2001 .

[28]  R. Royall.  The Effect of Sample Size on the Meaning of Significance Tests , 1986 .

[29]  D. Kandel,et al.  From beer to crack: developmental patterns of drug involvement. , 1993, American journal of public health.

[30]  M. Höfler,et al.  The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults. , 2001, Drug and alcohol dependence.

[31]  Michael Höfler,et al.  Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study. , 2002, Drug and alcohol dependence.

[32]  D. Collett.  Modelling survival data , 1994 .

[33]  Rupert G. Miller,et al.  Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.

[34]  A. Parrott.  Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research , 2001, Human psychopharmacology.

[35]  Jörg Daumann,et al.  High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users , 2000, Neuropsychopharmacology.

[36]  R. Bell,et al.  Stepping through the drug use sequence: longitudinal scalogram analysis of initiation and regular use. , 1992, Journal of abnormal psychology.

[37]  P. Bentler,et al.  A comparison of two latent variable causal models for adolescent drug use. , 1981, Journal of personality and social psychology.

[38]  M. Höfler,et al.  Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. , 1999, Addiction.

[39]  G. Chiara,et al.  Behavioural sensitization after repeated exposure to Δ9-tetrahydrocannabinol and cross-sensitization with morphine , 2001, Psychopharmacology.

[40]  L. Degenhardt,et al.  Patterns of ecstasy use in Australia: findings from a national household survey. , 2004, Addiction.

[41]  S. Goldberg,et al.  Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data , 2003, Psychopharmacology.

[42]  H. Wittchen.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review. , 1994, Journal of psychiatric research.

[43]  H. Wittchen,et al.  DSM-IV alcohol disorders in a general population sample of adolescents and young adults. , 1998, Addiction.

[44]  D. Kandel,et al.  Cross-cultural perspectives on developmental stages in adolescent drug use. , 1981, Journal of studies on alcohol.

[45]  A. Lees,et al.  Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits , 1998, Journal of psychopharmacology.

[46]  H. Wittchen,et al.  The Early Developmental Stages of Psychopathology Study (EDSP): A Methodological Update , 2000, European Addiction Research.

[47]  E. Goode.  Chapter 12 – MARIJUANA USE AND THE PROGRESSION TO DANGEROUS DRUGS* , 1974 .

[48]  I. Wickelgren.  Marijuana: Harder Than Thought? , 1997, Science.

[49]  J. Brook,et al.  Sequences of Drug Involvement in African-American and Puerto Rican Adolescents , 1992, Psychological reports.

[50]  H. Wittchen,et al.  Mental disorders in ecstasy users: a prospective-longitudinal investigation. , 2002, Drug and alcohol dependence.

[51]  Ronald C. Kessler,et al.  Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. , 1994 .

[52]  D. Kandel,et al.  Sequence and stages in patterns of adolescent drug use. , 1975, Archives of general psychiatry.

[53]  F. Smit,et al.  Polydrug Use Among Secondary School Students: combinations, prevalences and risk profiles , 2002 .

[54]  P. Schuster,et al.  Is the Use of Ecstasy and Hallucinogens Increasing? , 1998, European Addiction Research.

[55]  H. Kalant,et al.  The Health Effects of Cannabis , 1999 .

[56]  D. McCaffrey,et al.  Reassessing the marijuana gateway effect. , 2002, Addiction.

[57]  H. Wittchen,et al.  SKID. Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Handanweisung , 1997 .

[58]  H. Wittchen,et al.  Smoking and Nicotine Dependence , 1998, European Addiction Research.

[59]  W. Hall,et al.  Epidemiology of cannabis use and its consequences , 1999 .

[60]  M. Dimatteo,et al.  Structural-equation models of current drug use: are appropriate models so simple(x)? , 1987, Journal of personality and social psychology.

[61]  S. Pudney.  The Road to Ruin? Sequences of Initiation to Drugs and Crime in Britain* , 2003 .

[62]  H. Wittchen,et al.  Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI) , 1998, Social Psychiatry and Psychiatric Epidemiology.